Letter: metabolic dysfunction-associated fatty liver disease increases risk of all-cause mortality in patients with chronic hepatitis C

被引：0
|
作者：
Zhao, Qianwen [1 ]
Deng, Yunlei [2 ]
机构：
[1] Sichuan Univ, Sichuan Univ Univ Oxford Huaxi Joint Ctr Gastroint, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Peoples R China
[2] Southwest Jiaotong Univ, Peoples Hosp 3, Dept Nephrol, Affiliated Hosp, 82 Qinglong St, Chengdu 610031, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 02期
关键词：
D O I：
10.1111/apt.17294
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Attia et al paper. To view this article, visit
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [31] Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
    Jung, Han Na
    Jung, Chang Hee
    DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 198 - 200
  • [32] Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study
    Xie, Zhi-Qin
    Li, Hong-Xia
    Wang, Bing-Kun
    Yang, Zhao-Ming
    Zhang, Zi-Yu
    Tan, Wen-Liang
    Li, Wen-Xin
    Wang, Qing-Bin
    Yang, Lei
    Zhuang, Hong-Kai
    Tang, Chen-Wei
    Shang, Chang-Zhen
    Chen, Ya-Jin
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 110 : 62 - 70
  • [33] Letter to the editor: Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
    Li, Hong-Xia
    Xie, Zhi-Qin
    Yang, Zhao-Ming
    Tang, Cai-Xi
    HEPATOLOGY, 2022,
  • [34] Letter to the Editor: Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
    Li, Hong-Xia
    Xie, Zhi-Qin
    Yang, Zhao-Ming
    Tang, Cai-Xi
    HEPATOLOGY, 2023, 77 (04) : E67 - E68
  • [35] STATIN USE WITH CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY IN PATIENTS WITH HYPERTENSION, METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE, AND OBESITY: A POPULATION-BASED COHORT STUDY
    Abaalkhail, Arunkumar Krishnan Faisal
    Althwanay, Aldanah
    Woreta, Tinsay
    Alqahtani, Saleh
    HEPATOLOGY, 2024, 80 : S894 - S895
  • [36] Risk Factors for Advanced Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sachar, Moniyka
    Pan, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S561 - S561
  • [37] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [38] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
  • [39] Association between the Life's essential 8 health behaviors score and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease
    Han, Yan
    Tang, Jing
    Wu, Na
    Li, Zhao
    Ren, Hong
    Hu, Peng
    Chen, Zhiwei
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 163
  • [40] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
12345